Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study

OBJECTIVE: The effect of adalimumab on hand osteoporosis was examined and related to radiographic joint damage in the three treatment arms of the PREMIER study: adalimumab plus methotrexate, adalimumab and methotrexate monotherapy. Predictors of hand bone loss were also searched for. METHODS: 768 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoff, M, Kvien, T K, Kälvesten, J, Elden, A, Haugeberg, G
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689520/
https://www.ncbi.nlm.nih.gov/pubmed/18801760
http://dx.doi.org/10.1136/ard.2008.091264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689520/
https://www.ncbi.nlm.nih.gov/pubmed/18801760
http://dx.doi.org/10.1136/ard.2008.091264

Ejemplares similares